HEPHAISTOS-Pharma

HEPHAISTOS-Pharma is a biotech company in Orsay, France, founded in 2018. It has raised $7.6M across 2 rounds, most recently a $5.2M Extension Round in May 2024.

Hephaïstos - Hephaistos Pharma

Headquarters
Orsay
Employees
1–10
Founded
2018
Business Model
B2B
Total Funding
$7.6M
Last Round
$5.2M Extension RoundMay 2024
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 3 investors for this company. The full record is or through the API.

About

HEPHAISTOS-Pharma is a biopharmaceutical company developing 3rd generation TLR4 agonist small-molecule innate immune boosters designed to convert myeloid-rich, immunosuppressive tumors into immunotherapy-responsive tumors. The companys lead drug candidate, HEPHA440, has demonstrated compelling anti-tumor activity across a broad spectrum of preclinical cancer models both as a monotherapy and in combination with checkpoint inhibitors, with clinical trials planned for 2027. Founded in 2018 and headquartered in Orsay, France, HEPHAISTOS-Pharma has secured 10.3M in funding and is backed by investors including Elaia.

Summary

It lists 1–10 employees. It has raised $7.6M in total across 2 rounds, most recently a $5.2M Extension Round in May 2024. Investors include XISTA Science Ventures, Elaia and Noshaq.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Extension RoundExtension RoundMay 2024
$5.2M

Sign up to see all 2 events

Funding: Seed through Extension Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

HEPHAISTOS-Pharma on Indexed.vc
<a href="https://indexed.vc/companies/hephaistos-pharma"><img src="https://indexed.vc/api/badge/company/hephaistos-pharma" alt="HEPHAISTOS-Pharma on Indexed.vc" width="260" height="76" /></a>